| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.006 |